Washington University School of Medicine
- Consultant: AstraZeneca LP; Bristol-Myers Squibb; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Lundbeck; Organon Pharmaceuticals USA Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Solvay S.A; Tikvah Therapeutics, Inc.; Vanda; Wyeth
- Data Safety Monitoring Committee: Dainippon Sumitomo Pharma America, Inc.; Organon Pharmaceuticals USA Inc.; Schering-Plough; Vivus, Inc.
- Grant Support: Bristol-Myers Squibb; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute of Mental Health (NIMH); Pfizer Inc; Wyeth